Therapeutic effect by spherical oral adsorbent(Kremezin&reg;) on vascular endothelial function in type 2 diabetic patients with overt nephropathy. - Therapeutic effect by spherical oral adsorbent(Kremezin&reg;) on vascular endothelial function in type 2 diabetic patients with overt nephropathy.

Kanazawa Medical University Diabetes and Endocrinology0 个研究点目标入组 30 人开始时间: 2011年7月15日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Exclusion Criteria Patients that meet any of the following Exclusion Criteria must not be enrolled into the study: 1) Patients with transit disorder in the digestive tract or peptic ulcer and esophageal varix (this product may irritate affected area.) and patients whom physician judges as inappropriate 2) Patients with a predisposition to severe and habitual constipation (this product may exacerbate constipation) and patients whom physician judges as inappropriate 3) Patients with severe ketosis, diabetic coma, or precoma 4) Patients with severe infection, before and after operation, or severe injury 5) Patients with hematuria 6) Patients with a previous history of medication allergy 7) Patients who is currently pregnant, or plan to become pregnant during the study period 8) Patients with active diabetic proliferative retinopathy (except for patients with proliferative retinopathy who conducted retinal photocoagulation therapy and were stable on the retina) 9) Patients whom physician determines as inappropriate

发起方

Kanazawa Medical University Diabetes and Endocrinology